-
EP3624834
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3624834
| EP3624834 - TRANSGENIC MACROPHAGES, CHIMERIC ANTIGEN RECEPTORS, AND ASSOCIATED METHODS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 26.08.2022 Database last updated on 24.01.2025 | |
| Former | Request for examination was made Status updated on 21.02.2020 | ||
| Former | The international publication has been made Status updated on 23.11.2018 | ||
| Former | unknown Status updated on 29.06.2017 | Most recent event Tooltip | 28.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Thunder Biotech Inc. 730 East 100 North Alpine, Utah 84004 / US | [2020/13] | Inventor(s) | 01 /
O'NEILL, Kim 1671 North 1670 West Grandview Provo, Utah 84604 / US | [2020/13] | Representative(s) | Algemeen Octrooi- en Merkenbureau B.V. P.O. Box 645 5600 AP Eindhoven / NL | [2020/13] | Application number, filing date | 17731332.7 | 17.05.2017 | [2020/13] | WO2017US33039 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018212770 | Date: | 22.11.2018 | Language: | EN | [2018/47] | Type: | A1 Application with search report | No.: | EP3624834 | Date: | 25.03.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.11.2018 takes the place of the publication of the European patent application. | [2020/13] | Search report(s) | International search report - published on: | EP | 22.11.2018 | Classification | IPC: | A61K39/00, A61K35/15, C07K16/40 | [2020/13] | CPC: |
C07K16/40 (EP,KR);
A61K40/4257 (EP,US);
A61K39/001162 (KR);
A61K40/17 (EP,US);
A61K40/24 (EP,US);
A61K40/31 (EP,US);
A61K40/4204 (EP,US);
A61K40/4205 (EP,US);
A61K40/4215 (EP,US);
A61K40/422 (EP,US);
A61K40/4244 (EP,US);
A61K40/4251 (EP,US);
A61K40/4255 (EP,US);
A61K40/4258 (EP,US);
A61K40/4266 (EP,US);
A61P35/00 (EP,KR);
C07K16/30 (EP,KR);
A61K2039/5154 (KR);
A61K2039/5156 (KR);
A61K2039/5158 (KR);
A61K2239/13 (EP,US);
A61K2239/21 (EP,US);
A61K2239/55 (EP,US);
A61K38/00 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/13] | Title | German: | TRANSGENE MAKROPHAGEN, CHIMÄRE ANTIGENREZEPTOREN UND ZUGEHÖRIGE VERFAHREN | [2020/13] | English: | TRANSGENIC MACROPHAGES, CHIMERIC ANTIGEN RECEPTORS, AND ASSOCIATED METHODS | [2020/13] | French: | MACROPHAGES TRANSGÉNIQUES, RÉCEPTEURS D'ANTIGÈNES CHIMÉRIQUES ET MÉTHODES ASSOCIÉES | [2020/13] | Entry into regional phase | 05.12.2019 | National basic fee paid | 05.12.2019 | Designation fee(s) paid | 05.12.2019 | Examination fee paid | Examination procedure | 05.12.2019 | Amendment by applicant (claims and/or description) | 05.12.2019 | Examination requested [2020/13] | 05.12.2019 | Date on which the examining division has become responsible | 25.08.2022 | Despatch of a communication from the examining division (Time limit: M06) | 27.02.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 05.12.2019 | Renewal fee patent year 03 | 22.05.2020 | Renewal fee patent year 04 | 18.05.2021 | Renewal fee patent year 05 | 25.05.2022 | Renewal fee patent year 06 | 30.05.2023 | Renewal fee patent year 07 | 28.05.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2017019848 (UNIV PENNSYLVANIA [US]); | [A]WO2017025944 (UNIV BRIGHAM YOUNG [US]) | by applicant | FR2422956 | FR2464269 | FR2518755 |